F16.21 - Hallucinogen dependence, in remission
- Applicable to Hallucinogen dependence, in remission
- The 2025 edition of ICD10-CM F16.21 became effective on October 1, 2024.
- This is the American ICD10-CM version of F16.21 - other international versions of ICD10 F16.21 may differ.
- F16.21 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Inclusion Term
- Other hallucinogen use disorder, moderate, in early remission
- Other hallucinogen use disorder, moderate, in sustained remission
- Other hallucinogen use disorder, severe, in early remission
- Other hallucinogen use disorder, severe, in sustained remission
- Phencyclidine use disorder, moderate, in early remission
- Phencyclidine use disorder, moderate, in sustained remission
- Phencyclidine use disorder, severe, in early remission
- Phencyclidine use disorder, severe, in sustained remission
The following codes above F16.21 contain annotation back-references that may be applicable to F16.21:
Chapter: F01-F99 Mental, Behavioral and Neurodevelopmental disorders
Section: F10-F19 Mental and behavioral disorders due to psychoactive substance use
Category: F16 Hallucinogen related disorders
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com